Table 5.
Outcomes measured using the earable devices by prevention stage.
|
|
Prevention stage, n (%) | Total (row; N=51), n (%) | ||||||||
|
|
Primary (n=12) | Secondary (n=35) | Tertiary (n=4) |
|
||||||
| Target health outcomes | ||||||||||
|
|
Diet-related | 7 (58) | 1 (3) | 1 (25) | 9 (18) | |||||
|
|
Brain status | 2 (17) | 5 (14) | —a | 7 (14) | |||||
|
|
Cardiovascular disease | — | 5 (14) | — | 5 (10) | |||||
|
|
Central nervous system disease | — | 4 (11) | 1 (25) | 5 (10) | |||||
|
|
Head injury | — | 4 (11) | — | 4 (8) | |||||
|
|
Heart status | — | 3 (9) | — | 3 (6) | |||||
|
|
Respiration | 1 (8) | 1 (3) | — | 2 (4) | |||||
|
|
Sleep disorder | — | 2 (6) | — | 2 (4) | |||||
|
|
Combination | — | 8 (23) | — | 8 (16) | |||||
|
|
Other | 2 (17) | 2 (6) | 2 (50) | 6 (12) | |||||
| Biomarkers | ||||||||||
|
|
EEGb | 1 (8) | 10 (29) | — | 11 (22) | |||||
|
|
Body movements | 3 (25) | 1 (3) | 2 (50) | 6 (12) | |||||
|
|
Body temperature | 1 (8) | 4 (11) | — | 5 (10) | |||||
|
|
PPGc | 1 (8) | 3 (9) | — | 4 (8) | |||||
|
|
Acceleration stress | — | 4 (11) | — | 4 (8) | |||||
|
|
ECGd | — | 3 (9) | — | 3 (6) | |||||
|
|
Combination | 5 (42) | 7 (20) | 1 (25) | 13 (25) | |||||
|
|
Other | 1 (8) | 3 (9) | 1 (25) | 5 (10) | |||||
| Sensor type | ||||||||||
|
|
Electric | 3 (25) | 15 (43) | 1 (25) | 19 (37) | |||||
|
|
Photo | 3 (25) | 4 (11) | 2 (50) | 9 (18) | |||||
|
|
Mechanical | 1 (8) | 4 (11) | — | 5 (10) | |||||
|
|
Thermal | 1 (8) | 1 (3) | 1 (25) | 3 (6) | |||||
|
|
Acoustic | — | 1 (3) | — | 1 (2) | |||||
|
|
Combination | 4 (33) | 10 (29) | — | 14 (27) | |||||
| Total (column; N=51) | 12 (24) | 35 (69) | 4 (8) | 51 (100) | ||||||
aNot available.
bEEG: electroencephalography.
cPPG: photoplethysmography.
dECG: electrocardiography.